Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Caris Life Sciences (CAI) Preferred Dividend Payments (2024 - 2025)

Caris Life Sciences (CAI) has 2 years of Preferred Dividend Payments data on record, last reported at $384.4 million in Q2 2025.

  • For Q2 2025, Preferred Dividend Payments changed N/A year-over-year to $384.4 million; the TTM value through Sep 2025 reached $434.1 million, changed N/A, while the annual FY2025 figure was $85.4 million, 11.35% down from the prior year.
  • Preferred Dividend Payments reached $384.4 million in Q2 2025 per CAI's latest filing, up from $49.7 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $384.4 million in Q2 2025 and bottomed at $49.7 million in Q4 2024.